Michael LaBarre
Direttore Tecnico/Scientifico/R&S presso HALOZYME THERAPEUTICS, INC.
Patrimonio netto: 9 M $ in data 30/06/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Connie Matsui | F | 70 | 18 anni | |
| Jeffrey Henderson | M | 59 | 9 anni | |
| Helen Torley | M | 61 | 10 anni | |
| Mark Snyder | M | 57 | 2 anni | |
| Nicole LaBrosse | F | 41 | 9 anni | |
| Barbara Duncan | F | 59 | 1 anni | |
| Matthew Posard | M | 56 | 11 anni | |
| Tram Bui | F | - | 2 anni | |
| Akiko Miyashita | F | 68 | 2 anni | |
| Bernadette Connaughton | F | 65 | 6 anni | |
| Amy Marinne Fox | F | - | 4 anni | |
| Steve Knowles | M | - | 6 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Gregory Ian Frost | M | 52 | 16 anni | |
| William Rastetter | M | 75 |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 19 anni |
| Jonathan Lim | M | 52 | 7 anni | |
| Kathryn Falberg | F | 63 | 9 anni | |
| Richard Miller | M | 73 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 18 anni |
| Harry Leonhardt | M | 67 | 5 anni | |
| John Dunn | M | 72 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 1 anni |
| Kenneth Kelley | M | 64 | 17 anni | |
| David Ramsay | M | 59 | 12 anni | |
| Kurt Gustafson | M | 55 | 4 anni | |
| Masaru Matsuda | M | 53 | 3 anni | |
| William R. Rohn | M | 80 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 12 anni |
| Albert Kildani | M | - | - | |
| Jean Bizzari | M | 69 | 9 anni | |
| James Daly | M | 62 | 8 anni | |
| John Stuart Patton | M | 77 | 25 anni | |
| James E. Cartoni | M | - | 3 anni | |
| Robert Engler | M | 79 | 11 anni | |
| Christine Anna White | M | 72 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 9 anni |
| Eric S. Hoffman | M | 54 | 5 anni | |
| William J. Fallon | M | - | 14 anni | |
| Phillip Schneider | M | 68 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 16 anni |
| Michael Paolucci | M | 64 | 5 anni | |
| William Mccarthy | M | - | 9 anni | |
| Homa Yeganegi | F | - | - | |
| Thomas Heineman | M | - | 2 anni | |
| Jim Mazzola | M | - | 3 anni | |
| Jonathan Leff | M | 66 | 1 anni | |
| Randal Kirk | M | 70 | 11 anni | |
| Jean Liu | F | 55 | 3 anni | |
| Mark Wiggins | M | 68 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | - |
| William Young | M | 79 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | - |
| Christopher Watt | M | 59 | 11 anni | |
| Michael E. Markels | M | - | 1 anni | |
| Nicolas Barthelemy | M | 58 | 8 anni | |
| Scott Anthony Climes | M | 59 | 2 anni | |
| Maiken Keson-Brookes | F | 51 | 5 anni | |
| Stephen Daly | M | - | - | |
| Sunil Joshi | M | - | 2 anni | |
| Richard Francis | M | 55 | 8 anni | |
| Laurie Stelzer | F | 56 | 5 anni | |
| Ben Harshbarger | M | 55 | 5 anni | |
| Andrea DiFabio | F | 55 | 11 anni | |
| Robert J. Little | M | 74 | 4 anni | |
| James Kelly | M | 58 | 5 anni | |
| Schond Greenway | M | 52 | 3 anni | |
| Dimitrios Chondros | M | 59 | 5 anni | |
| Benjamin Hickey | M | 50 | 2 anni | |
| James Basta | M | 58 | - | |
| David Mitchell | M | 67 | 4 anni | |
| Joseph J. Kenny | M | - | 5 anni | |
| Michael Pollock | M | - | 2 anni | |
| Susie Melody | F | - | 2 anni | |
| Jeff Knight | M | 52 | 1 anni | |
| Mann Muhsin | M | - | 3 anni | |
| Bethany Sensenig | F | 48 | 13 anni | |
| Esther Alegria | M | 65 | 10 anni | |
| Mark E. Erwin | M | 59 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 4 anni |
| Robert Gagnon | M | 49 | 7 anni | |
| Timothy Kelly | M | 55 | 7 anni | |
| Robert W. Pangia | M | 72 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | - |
| Antonio J. Grillo-López | M | 84 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 11 anni |
| Alan B. Glassberg | M | 87 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | - |
| Philip Gotwals | M | 61 | 2 anni | |
| Arturo Molina | M | 65 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 1 anni |
| David Hallal | M | 56 | 2 anni | |
| David Parkinson | M | 73 | 1 anni | |
| Stephen Tulipano | M | 65 | 8 anni | |
| Matthew Onaitis | M | 53 | - | |
| Jim Shaffer | M | 57 | 3 anni | |
| Katherine J. Turner | M | 70 | 4 anni | |
| Bonne Adams | F | 47 | 2 anni | |
| Melissa Morandi | F | 59 | 2 anni | |
| Bruce R. Ross | M | 83 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | - |
| Faheem Hasnain | M | 65 | 4 anni | |
| Robert Peach | M | 68 | 2 anni | |
| E. J. Brandreth | M | - |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 7 anni |
| Dinah Sah | M | 63 | 6 anni | |
| Daniel Char | M | 63 | 11 anni | |
| Pratik Multani | M | 57 | 5 anni | |
| Akshay Vaishnaw | M | 61 | 7 anni | |
| Douglas A. Abel | M | 62 | 4 anni | |
| Alessandra Cesano | M | 63 | 2 anni | |
| Anne Cook | F | 62 | 13 anni | |
| Allen Kamer | M | 53 | 3 anni | |
| Michael Gilman | M | 69 | 6 anni | |
| Eric W. Kimble | M | 58 | 5 anni | |
| Eugene Park | M | - | 1 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Michael LaBarre
- Contatti personali
